Zurich, Switzerland

Vania Manolova

This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Cytos Biotechnology Ag, Cytis Biotechnology Ag. Active years: 2009-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vania Manolova. Retrieved from https://idiyas.com/inventor/vania-manolova-34h6d29r

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 33.3


Average Co-Inventor Count = 7.0

ph-index = 3

Forward Citations = 86(Granted Patents)


Location History:

  • Zurich, CH (2009)
  • Zürich, CH (2009 - 2013)

Company Filing History:


Years Active: 2009-2013

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Sure! Here's the article about inventor Vania Manolova:

Title: Vania Manolova: Pioneering Innovator in Technology Advancement

Introduction:

Vania Manolova, a visionary inventor based in Zurich, Switzerland, is a trailblazer in the field of technological advancement. With a passion for innovation and a relentless pursuit of progress, she continues to inspire the next generation of inventors worldwide.

Latest Patents:

1. "Immunostimulatory Nucleic Acid Packaged Particles for the Treatment of Hypersensitivity": This patent application focuses on compositions and methods for treating hypersensitivity conditions such as atopic eczema, asthma, and pollen allergies using immunostimulatory nucleic acids.

2. "Melan-A Carrier Conjugates": In this groundbreaking invention, Vania Manolova introduces modified virus-like particles loaded with immunostimulatory substances and peptides derived from MelanA. These innovative CpG-loaded VLPs show enhanced immunogenicity and efficacy in inducing immune responses against allergies, tumors, and chronic viral diseases.

Career Highlights:

Vania Manolova has made significant contributions to the fields of molecular biology, virology, and immunology during her tenure at leading biotechnology companies such as Cytos Biotechnology and Cytis Biotechnology. Her inventive spirit and dedication to scientific exploration have led to the development of cutting-edge technologies with far-reaching implications.

Collaborations:

Throughout her career, Vania Manolova has collaborated closely with esteemed colleagues such as Martin F Bachmann and Patrik Maurer. Together, they have pushed the boundaries of scientific discovery and worked towards creating innovative solutions to complex medical challenges.

Conclusion:

In conclusion, Vania Manolova's remarkable achievements in the realm of technology and biotechnology reflect her unwavering commitment to driving progress and fostering innovation. Her legacy as a pioneering inventor will undoubtedly inspire future generations to push the boundaries of what is possible in the world of science and technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…